Products

Nabi Biopharmaceuticals currently markets two products that address serious, unmet medical needs. These products focus on the prevention of Hepatitis B infection following acute exposure to the Hepatitis B virus; and management of elevated serum and urinary uric acid levels in patients receiving chemotherapy for leukemias, lymphomas or some solid tumor cancers and who cannot tolerate oral therapy. 

Code No. 10355-00-GEN-061206